| 000 | 01093 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250518030247.0 | ||
| 264 | 0 | _c20200515 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1756-8722 | ||
| 024 | 7 |
_a10.1186/s13045-019-0718-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQin, Shuang | |
| 245 | 0 | 0 |
_aRecent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy. _h[electronic resource] |
| 260 |
_bJournal of hematology & oncology _c03 2019 |
||
| 300 |
_a27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 700 | 1 | _aLi, Anping | |
| 700 | 1 | _aYi, Ming | |
| 700 | 1 | _aYu, Shengnan | |
| 700 | 1 | _aZhang, Mingsheng | |
| 700 | 1 | _aWu, Kongming | |
| 773 | 0 |
_tJournal of hematology & oncology _gvol. 12 _gno. 1 _gp. 27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13045-019-0718-5 _zAvailable from publisher's website |
| 999 |
_c29473013 _d29473013 |
||